Vireo Growth (VREOF) Selling, General & Administrative (2020 - 2026)
Vireo Growth (VREOF) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Vireo Growth | 493.25 Mn | 350.95 Mn | 95.30 Mn | 75.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.80 Mn |
| Dec 31, 2025 | 31.58 Mn |
| Sep 30, 2025 | 29.68 Mn |
| Jun 30, 2025 | 12.45 Mn |
| Mar 31, 2025 | 7.40 Mn |
| Dec 31, 2024 | 6.54 Mn |
| Sep 30, 2024 | 6.91 Mn |
| Jun 30, 2024 | 7.56 Mn |
| Mar 31, 2024 | 7.05 Mn |
| Dec 31, 2023 | 6.25 Mn |
| Sep 30, 2023 | 6.75 Mn |
| Jun 30, 2023 | 8.06 Mn |
| Mar 31, 2023 | 7.16 Mn |
| Dec 31, 2022 | 7.43 Mn |
| Sep 30, 2022 | 8.49 Mn |
| Jun 30, 2022 | 8.63 Mn |
| Mar 31, 2022 | 9.28 Mn |
| Dec 31, 2021 | 9.21 Mn |
| Sep 30, 2021 | 8.11 Mn |
| Jun 30, 2021 | 8.30 Mn |